Market Closed - Xetra 11:38:07 2024-05-31 am EDT 5-day change 1st Jan Change
47.65 EUR +2.14% Intraday chart for Stratec SE +6.24% +4.61%
Sales 2024 * 266M 288M Sales 2025 * 290M 314M Capitalization 579M 628M
Net income 2024 * 16M 17.35M Net income 2025 * 23M 24.94M EV / Sales 2024 * 2.62 x
Net Debt 2024 * 116M 126M Net Debt 2025 * 79.62M 86.35M EV / Sales 2025 * 2.27 x
P/E ratio 2024 *
35.5 x
P/E ratio 2025 *
24.9 x
Employees 1,473
Yield 2024 *
1.83%
Yield 2025 *
1.91%
Free-Float 59.43%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.14%
1 week+6.24%
1 month+10.05%
3 months+10.56%
6 months+20.48%
Current year+4.61%
More quotes
1 week
45.20
Extreme 45.2
47.65
1 month
40.55
Extreme 40.55
47.65
Current year
36.25
Extreme 36.25
47.65
1 year
36.00
Extreme 36
69.00
3 years
36.00
Extreme 36
147.40
5 years
36.00
Extreme 36
147.40
10 years
34.95
Extreme 34.95
147.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 98-02-28
Director of Finance/CFO 57 98-04-30
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 58 19-05-28
Chairman 66 22-05-19
Director/Board Member 71 20-07-20
More insiders
Date Price Change Volume
24-05-31 47.65 +2.14% 23,177
24-05-30 46.65 +2.08% 7,201
24-05-29 45.7 -1.40% 6,795
24-05-28 46.35 +0.87% 3,931
24-05-27 45.95 +2.45% 1,796

Delayed Quote Xetra, May 31, 2024 at 11:38 am EDT

More quotes
Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
47.65 EUR
Average target price
42.33 EUR
Spread / Average Target
-11.16%
Consensus

Quarterly revenue - Rate of surprise